0001235802-22-000112.txt : 20221006 0001235802-22-000112.hdr.sgml : 20221006 20221006172935 ACCESSION NUMBER: 0001235802-22-000112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221004 FILED AS OF DATE: 20221006 DATE AS OF CHANGE: 20221006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STANKOVICH THOMAS CENTRAL INDEX KEY: 0001181166 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37897 FILM NUMBER: 221298821 MAIL ADDRESS: STREET 1: 1001 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ReShape Lifesciences Inc. CENTRAL INDEX KEY: 0001427570 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 BUSINESS PHONE: 949-429-6680 MAIL ADDRESS: STREET 1: 1001 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 FORMER COMPANY: FORMER CONFORMED NAME: OBALON THERAPEUTICS INC DATE OF NAME CHANGE: 20080220 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-10-04 0 0001427570 ReShape Lifesciences Inc. RSLS 0001181166 STANKOVICH THOMAS 1001 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 CFO Common Stock, $0.001 par value per share 2022-10-04 4 S 0 5809 0.2807 D 341154 D Common Stock, $0.001 par value per share 2022-10-04 4 S 0 2484 0.2812 D 338670 D On July 22, 2021, Mr. Stankovich was awarded an aggregate of 372,744 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units. /s/ Thomas Stankovich 2022-10-06